Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131306) titled 'Safety and Efficacy of Ultrasound-Guided Percutaneous Adrenal Ablation in the Treatment of Hypertension Caused by Primary Aldosteronism' on Sept. 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Medical Center of the Chinese PLA General Hospital

Condition: Hypertension due to primary aldosteronism

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-09-01

Target Sample Size: experimental group:31;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=334259

Disclaimer: Curated by HT Syndication...